20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Operating Income 2024–2025
20/20 Biolabs, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- 20/20 Biolabs, Inc. operating income for the quarter ending March 31, 2026 was -1.4 M, a 86.92% increase year-over-year.
- 20/20 Biolabs, Inc. annual operating income for 2025 was -3.3 M, a 41.33% decrease from 2024.
- 20/20 Biolabs, Inc. annual operating income for 2024 was -5.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
20/20 Biolabs, Inc. Operating Income — FAQ
20/20 Biolabs, Inc. (AIDX) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is 20/20 Biolabs, Inc.'s operating income?
20/20 Biolabs, Inc. (AIDX) reported operating income of -$3M for fiscal 2025.
Where can I see AIDX's operating income history?
The chart and table above show 20/20 Biolabs, Inc.'s operating income by year and by quarter, including the growth rate.